SpringerLink
Log in

Integrated Management of Scabies and Other Parasitic Diseases

  • Chapter
  • First Online:
Scabies

  • 225 Accesses

Abstract

In resource-poor communities, scabies is often coprevalent with other parasitic infections associated with overcrowding and poverty, many of which are neglected tropical diseases (NTDs). Integrated management of multiple diseases is generally more cost-effective, and scabies prevalence and transmission assessments can be added to control and elimination programs for other NTDs. Scabies management with mass drug administration of ivermectin is simple, as this drug is utilized in several NTD preventive chemotherapy and transmission control programs (such as onchocerciasis, lymphatic filariasis, and strongyloidiasis). Scabies integration into other NTD programs would also include development of guidelines for initiation and implementation of public health interventions, and a shift from disease-specific vertical programs to horizontal programs. Integrated One Health approaches are needed, including public health professionals, community health workers, nurses, physicians, school teachers, and veterinarians.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Karimkhani C, Colombara DV, Drucker AM, et al. The global burden of scabies: a cross-sectional analysis from the global burden of disease study 2015. Lancet Infect Dis. 2017;17(12):1247–54. https://doi.org/10.1016/S1473-3099(17)30483-8.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Heukelbach J, Feldmeier H. Scabies. Lancet. 2006;367(9524):1767–74. https://doi.org/10.1016/S0140-6736(06)68772-2.

    Article  PubMed  Google Scholar 

  3. Heukelbach J, Mazigo HD, Ugbomoiko US. Impact of scabies in resource-poor communities. Curr Opin Infect Dis. 2013;26(2):127–32. https://doi.org/10.1097/QCO.0b013e32835e847b.

    Article  PubMed  Google Scholar 

  4. Hay RJ, Steer AC, Engelman D, Walton S. Scabies in the develo** world—its prevalence, complications, and management. Clin Microbiol Infect. 2012;18(4):313–23. https://doi.org/10.1111/j.1469-0691.2012.03798.x.

    Article  CAS  PubMed  Google Scholar 

  5. Ugbomoiko US, Oyedeji SA, Babamale OA, Heukelbach J. Scabies in resource-poor communities in Nasarawa state, Nigeria: epidemiology, clinical features and factors associated with infestation. Trop Med Infect Dis. 2018;3(2):59. https://doi.org/10.3390/tropicalmed3020059.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Jackson A, Heukelbach J, Feldmeier H. Transmission of scabies in a rural community. Braz J Infect Dis. 2007;11(4):386–7.

    Article  PubMed  Google Scholar 

  7. Kearns TM, Currie BJ, Cheng AC, et al. Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian aboriginal community. PLoS Negl Trop Dis. 2017;11(5):e0005607. https://doi.org/10.1371/journal.pntd.0005607.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Mohammed KA, Deb RM, Stanton MC, Molyneux DH. Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis—a rapid assessment methodology to assess impact. Parasit Vectors. 2012;5:299. https://doi.org/10.1186/1756-3305-5-299.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Martin D, Wiegand R, Goodhew B, Lammie P, Mkocha H, Kasubi M. Impact of ivermectin mass drug administration for lymphatic filariasis on scabies in eight villages in Kongwa District, Tanzania. Am J Trop Med Hyg. 2018;99:937. https://doi.org/10.4269/ajtmh.18-0018.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Heukelbach J, Winter B, Wilcke T, et al. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull World Health Organ. 2004;82(8):563–71.

    PubMed  PubMed Central  Google Scholar 

  11. Chandler DJ, Fuller LC. The skin-A common pathway for integrating diagnosis and management of NTDs. Trop Med Infect Dis. 2018;3(3):101. https://doi.org/10.3390/tropicalmed3030101.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Engelman D, Fuller LC, Solomon AW, et al. Opportunities for integrated control of neglected tropical diseases that affect the skin. Trends Parasitol. 2016;32:843. https://doi.org/10.1016/j.pt.2016.08.005.

    Article  PubMed  Google Scholar 

  13. Yotsu RR. Integrated Management of Skin NTDs-lessons learned from existing practice and field research. Trop Med Infect Dis. 2018;3(4):120. https://doi.org/10.3390/tropicalmed3040120.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Heukelbach J, Feldmeier H. Ectoparasites—the underestimated realm. Lancet. 2004;363(9412):889–91. https://doi.org/10.1016/S0140-6736(04)15738-3.

    Article  PubMed  Google Scholar 

  15. Worth C, Heukelbach J, Fengler G, et al. Acute morbidity associated with scabies and other ectoparasitoses rapidly improves after treatment with ivermectin. Pediatr Dermatol. 2012;29(4):430–6. https://doi.org/10.1111/j.1525-1470.2011.01680.x.

    Article  PubMed  Google Scholar 

  16. Heukelbach J, Wilcke T, Winter B, Feldmeier H. Epidemiology and morbidity of scabies and pediculosis capitis in resource-poor communities in Brazil. Br J Dermatol. 2005;153(1):150–6. https://doi.org/10.1111/j.1365-2133.2005.06591.x.

    Article  CAS  PubMed  Google Scholar 

  17. Elfaituri SS. Skin diseases among internally displaced Tawerghans living in camps in Benghazi, Libya. Int J Dermatol. 2016;55(9):1000–4. https://doi.org/10.1111/ijd.13115.

    Article  PubMed  Google Scholar 

  18. Kortas AZ, Polenz J, von Hayek J, et al. Screening for infectious diseases among asylum seekers newly arrived in Germany in 2015: a systematic single-centre analysis. Public Health. 2017;153:1–8. https://doi.org/10.1016/j.puhe.2017.07.011.

    Article  CAS  PubMed  Google Scholar 

  19. Brouqui P, Stein A, Dupont HT, et al. Ectoparasitism and vector-borne diseases in 930 homeless people from Marseilles. Medicine (Baltimore). 2005;84(1):61–8.

    Article  PubMed  Google Scholar 

  20. Arnaud A, Chosidow O, Détrez M-A, et al. Prevalences of scabies and pediculosis corporis among homeless people in the Paris region: results from two randomized cross-sectional surveys (HYTPEAC study). Br J Dermatol. 2016;174(1):104–12. https://doi.org/10.1111/bjd.14226.

    Article  PubMed  Google Scholar 

  21. Walker SL, Lebas E, De Sario V, et al. The prevalence and association with health-related quality of life of tungiasis and scabies in schoolchildren in Southern Ethiopia. PLoS Negl Trop Dis. 2017;11(8):e0005808. https://doi.org/10.1371/journal.pntd.0005808.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Schmeller W, Dzikus A. Skin diseases in children in rural Kenya: long-term results of a dermatology project within the primary health care system. Br J Dermatol. 2001;144(1):118–24.

    Article  CAS  PubMed  Google Scholar 

  23. Hotez PJ, Alvarado M, Basanez MG, et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis. 2014;8(7):e2865. https://doi.org/10.1371/journal.pntd.0002865.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Hay RJ, Castanon RE, Hernandez HA, et al. Wastage of family income on skin disease in Mexico. BMJ. 1994;309(6958):848. https://doi.org/10.1136/bmj.309.6958.848.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. World Health Organization. Ethiopia—Scabies outbreak response in Amhara regional state. WHO|Regional Office for Africa. https://afro.who.int/news/ethiopia-scabies-outbreak-response-amhara-regional-state. Accessed 6 Jan 2019.

  26. Hofstraat K, van Brakel WH. Social stigma towards neglected tropical diseases: a systematic review. Int Health. 2016;8(suppl 1):i53–70. https://doi.org/10.1093/inthealth/ihv071.

    Article  PubMed  Google Scholar 

  27. **-gang A, Sheng-xiang X, Sheng-bin X, et al. Quality of life of patients with scabies. J Eur Acad Dermatol Venereol. 2010;24(10):1187–91. https://doi.org/10.1111/j.1468-3083.2010.03618.x.

    Article  CAS  PubMed  Google Scholar 

  28. Lewis-Jones MS, Finlay AY. The children’s dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942–9.

    Article  CAS  PubMed  Google Scholar 

  29. Olsen JR, Gallacher J, Finlay AY, Piguet V, Francis NA. Quality of life impact of childhood skin conditions measured using the children’s dermatology life quality index (CDLQI): a meta-analysis. Br J Dermatol. 2016;174(4):853–61. https://doi.org/10.1111/bjd.14361.

    Article  CAS  PubMed  Google Scholar 

  30. Worth C, Heukelbach J, Fengler G, Walter B, Liesenfeld O, Feldmeier H. Impaired quality of life in adults and children with scabies from an impoverished community in Brazil. Int J Dermatol. 2012;51(3):275–82. https://doi.org/10.1111/j.1365-4632.2011.05017.x.

    Article  PubMed  Google Scholar 

  31. Öztürkcan S, Ermertcan AT, Eser E, Şahin MT. Cross validation of the Turkish version of dermatology life quality index. Int J Dermatol. 2006;45(11):1300–7. https://doi.org/10.1111/j.1365-4632.2006.02881.x.

    Article  PubMed  Google Scholar 

  32. Porter JR, Beuf AH, Lerner A, Nordlund J. Psychosocial effect of vitiligo: a comparison of vitiligo patients with “normal” control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol. 1986;15(2 Pt 1):220–4.

    Article  CAS  PubMed  Google Scholar 

  33. Chandrasena TGAN, Premaratna R, Muthugala MARV, Pathmeswaran A, de Silva NR. Modified dermatology life quality index as a measure of quality of life in patients with filarial lymphoedema. Trans R Soc Trop Med Hyg. 2007;101(3):245–9. https://doi.org/10.1016/j.trstmh.2006.08.012.

    Article  CAS  PubMed  Google Scholar 

  34. Steer AC, Tikoduadua LV, Manalac EM, Colquhoun S, Carapetis JR, Maclennan C. Validation of an integrated management of childhood illness algorithm for managing common skin conditions in Fiji. Bull World Health Organ. 2009;87(3):173–9.

    Article  PubMed  PubMed Central  Google Scholar 

  35. World Health Organization. Recognizing neglected tropical diseases through changes on the skin. http://apps.who.int/iris/bitstream/handle/10665/272723/9789241513531-eng.pdf?ua=1. Accessed 3 Dec 2018.

  36. Knipes AK, Lemoine JF, Monestime F, et al. Partnering for impact: integrated transmission assessment surveys for lymphatic filariasis, soil transmitted helminths and malaria in Haiti. PLoS Negl Trop Dis. 2017;11(2):e0005387. https://doi.org/10.1371/journal.pntd.0005387.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Chu BK, Gass K, Batcho W, et al. Pilot assessment of soil-transmitted helminthiasis in the context of transmission assessment surveys for lymphatic filariasis in Benin and Tonga. PLoS Negl Trop Dis. 2014;8(2):e2708. https://doi.org/10.1371/journal.pntd.0002708.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Drabo F, Ouedraogo H, Bougma R, et al. Successful control of soil-transmitted helminthiasis in school age children in Burkina Faso and an example of community-based assessment via lymphatic Filariasis transmission assessment survey. PLoS Negl Trop Dis. 2016;10(5):e0004707. https://doi.org/10.1371/journal.pntd.0004707.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Gunawardena S, Gunawardena NK, Kahathuduwa G, et al. Integrated school-based surveillance for soil-transmitted helminth infections and lymphatic filariasis in Gampaha district, Sri Lanka. Am J Trop Med Hyg. 2014;90(4):661–6. https://doi.org/10.4269/ajtmh.13-0641.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Figueroa JI, Fuller LC, Abraha A, Hay RJ. The prevalence of skin disease among school children in rural Ethiopia—a preliminary assessment of dermatologic needs. Pediatr Dermatol. 1996;13(5):378–81.

    Article  CAS  PubMed  Google Scholar 

  41. Ferie J, Dinkela A, Mbata M, Idindili B, Schmid-Grendelmeier P, Hatz C. Skin disorders among school children in rural Tanzania and an assessment of therapeutic needs. Trop Dr. 2006;36(4):219–21. https://doi.org/10.1258/004947506778604823.

    Article  CAS  Google Scholar 

  42. Hogewoning A, Amoah A, Bavinck JN, et al. Skin diseases among schoolchildren in Ghana, Gabon, and Rwanda. Int J Dermatol. 2013;52(5):589–600. https://doi.org/10.1111/j.1365-4632.2012.05822.x.

    Article  PubMed  Google Scholar 

  43. Korte LM, Bowen AC, ADK D, et al. Scabies and impetigo in Timor-Leste: a school screening study in two districts. PLoS Negl Trop Dis. 2018;12(5):e0006400. https://doi.org/10.1371/journal.pntd.0006400.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Chang AY, Scheel A, Dewyer A, et al. Prevalence of skin conditions in schoolchildren in urban Western and Northern Uganda. Presented at the: American Society of Tropical Medicine & Hygiene meeting, November 6, 2017, Baltimore, MD. https://www.astmh.org/ASTMH/media/2017-Annual-Meeting/ASTMH-2017-Abstract-Book.pdf.

  45. Mahe A, Prual A, Konate M, Bobin P. Skin diseases of children in Mali: a public health problem. Trans R Soc Trop Med Hyg. 1995;89(5):467–70.

    Article  CAS  PubMed  Google Scholar 

  46. Jackson A, Heukelbach J, Filho AF, Junior Ede B, Feldmeier H. Clinical features and associated morbidity of scabies in a rural community in Alagoas, Brazil. Trop Med Int Health. 2007;12(4):493–502. https://doi.org/10.1111/j.1365-3156.2006.01809.x.

    Article  PubMed  Google Scholar 

  47. King CL, Suamani J, Sanuku N, et al. A trial of a triple-drug treatment for lymphatic filariasis. N Engl J Med. 2018;379(19):1801–10. https://doi.org/10.1056/NEJMoa1706854.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Engelman D, Fuller LC, Steer AC. International Alliance for the control of scabies Delphi panel. Consensus criteria for the diagnosis of scabies: a delphi study of international experts. PLoS Negl Trop Dis. 2018;12(5):e0006549. https://doi.org/10.1371/journal.pntd.0006549.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Marks M, Engelman D, Romani L, et al. Exploration of a simplified clinical examination for scabies to support public health decision-making. PLoS Negl Trop Dis. 2018;12(12):e0006996. https://doi.org/10.1371/journal.pntd.0006996.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Solomon AW, Pavluck AL, Courtright P, et al. The global trachoma map** project: methodology of a 34-country population-based study. Ophthalmic Epidemiol. 2015;22(3):214–25. https://doi.org/10.3109/09286586.2015.1037401.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Rosumeck S, Nast A, Dressler C. Ivermectin and permethrin for treating scabies. Cochrane Database Syst Rev. 2018;4:CD012994. https://doi.org/10.1002/14651858.CD012994.

    Article  PubMed  Google Scholar 

  52. Romani L, Whitfeld MJ, Koroivueta J, et al. Mass drug Administration for Scabies Control in a population with endemic disease. N Engl J Med. 2015;373(24):2305–13. https://doi.org/10.1056/NEJMoa1500987.

    Article  CAS  PubMed  Google Scholar 

  53. Kearns TM, Speare R, Cheng AC, et al. Impact of an ivermectin mass drug administration on scabies prevalence in a remote Australian aboriginal community. PLoS Negl Trop Dis. 2015;9(10):e0004151. https://doi.org/10.1371/journal.pntd.0004151.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Anosike JC, Dozie INS, Ameh GI, et al. The varied beneficial effects of ivermectin (Mectizan) treatment, as observed within onchocerciasis foci in South–Eastern Nigeria. Ann Trop Med Parasitol. 2007;101(7):593–600. https://doi.org/10.1179/136485907X229022.

    Article  CAS  PubMed  Google Scholar 

  55. Ottesen EA, Hooper PJ, Bradley M, Biswas G. The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis. 2008;2(10):e317. https://doi.org/10.1371/journal.pntd.0000317.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Tielsch JM, Beeche A. Impact of ivermectin on illness and disability associated with onchocerciasis. Tropical Med Int Health. 2004;9(4):A45–56. https://doi.org/10.1111/j.1365-3156.2004.01213.x.

    Article  CAS  Google Scholar 

  57. Krotneva SP, Coffeng LE, Noma M, et al. African program for onchocerciasis control 1995–2010: impact of annual ivermectin mass treatment on off-target infectious diseases. PLoS Negl Trop Dis. 2015;9(9):e0004051. https://doi.org/10.1371/journal.pntd.0004051.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Xu T-L, Han Y, Liu W, et al. Antivirus effectiveness of ivermectin on dengue virus type 2 in Aedes albopictus. PLoS Negl Trop Dis. 2018;12(11):e0006934. https://doi.org/10.1371/journal.pntd.0006934.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Alout H, Foy BD. Ivermectin: a complimentary weapon against the spread of malaria? Expert Rev Anti-Infect Ther. 2017;15(3):231–40. https://doi.org/10.1080/14787210.2017.1271713.

    Article  CAS  PubMed  Google Scholar 

  60. Alout H, Krajacich BJ, Meyers JI, et al. Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments. Malar J. 2014;13:417. https://doi.org/10.1186/1475-2875-13-417.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Smit MR, Ochomo EO, Aljayyoussi G, et al. Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2018;18(6):615–26. https://doi.org/10.1016/S1473-3099(18)30163-4.

    Article  CAS  PubMed  Google Scholar 

  62. Heukelbach J. One Health & Implementation Research: improving health for all. One Health Implement Res. 2020;1(1):1–3. https://doi.org/10.20517/ohir.2020.01.

    Article  Google Scholar 

  63. Centers for Disease Control & Prevention. Saving lives by taking a one health approach. https://www.cdc.gov/onehealth/pdfs/OneHealth-FactSheet-FINAL.pdf. Accessed 22 Jan 2019.

  64. Liu X, Walton S, Mounsey K. Vaccine against scabies: necessity and possibility. Parasitology. 2014;141(6):725–32. https://doi.org/10.1017/S0031182013002047.

    Article  PubMed  Google Scholar 

  65. Wilkins AL, Steer AC, Cranswick N, Gwee A. Question 1: is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg? Arch Dis Child. 2018;103(5):514–9. https://doi.org/10.1136/archdischild-2017-314505.

    Article  PubMed  Google Scholar 

  66. Chaccour C, Hammann F, Rabinovich NR. Ivermectin to reduce malaria transmission I. pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety. Malar J. 2017;16(1):161. https://doi.org/10.1186/s12936-017-1801-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Standley C, Boyce MR, Klineberg A, Essix G, Katz R. Organization of oversight for integrated control of neglected tropical diseases within ministries of health. PLoS Negl Trop Dis. 2018;12(11):e0006929. https://doi.org/10.1371/journal.pntd.0006929.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Ortu G, Williams O. Neglected tropical diseases: exploring long term practical approaches to achieve sustainable disease elimination and beyond. Infect Dis Poverty. 2017;6(1):147. https://doi.org/10.1186/s40249-017-0361-8.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Mitchell E, Bell S, Thean LJ, Sahukhan A, Kama M, Koroivueti A, Kaldor J, Steer A, Romani L. Community perspectives on scabies, impetigo and mass drug administration in Fiji: a qualitative study. PLoS Negl Trop Dis. 2020;14(12):e0008825. https://doi.org/10.1371/journal.pntd.0008825.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Mengitsu B, Shafi O, Kebede B, et al. Ethiopia and its steps to mobilize resources to achieve 2020 elimination and control goals for neglected tropical diseases: spider webs joined can tie a lion. Int Health. 2016;8(suppl_1):i34–52. https://doi.org/10.1093/inthealth/ihw007.

    Article  PubMed  Google Scholar 

  71. Mensah EO, Aikins MK, Gyapong M, Anto F, Bockarie MJ, Gyapong JO. Extent of integration of priority interventions into general health systems: a case study of neglected tropical diseases programme in the Western region of Ghana. PLoS Negl Trop Dis. 2016;10(5):e0004725. https://doi.org/10.1371/journal.pntd.0004725.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA

    Aileen Y. Chang

  2. Postgraduate Program of Public Health, School of Medicine, Federal University of Ceará, Fortaleza, Brazil

    Jorg Heukelbach

Authors
  1. Aileen Y. Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jorg Heukelbach
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aileen Y. Chang .

Editor information

Editors and Affiliations

  1. QIMR Berghofer Medical Research Institut, Herston, QLD, Australia

    Katja Fischer

  2. UPE-Université Paris-Est, Service de Dermatologie, Hôpital Henri Mondor, EA 7379 EpiDermE et INSERM CIC 1430, Créteil, France

    Olivier Chosidow

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chang, A.Y., Heukelbach, J. (2023). Integrated Management of Scabies and Other Parasitic Diseases. In: Fischer, K., Chosidow, O. (eds) Scabies. Springer, Cham. https://doi.org/10.1007/978-3-031-26070-4_31

Download citation

Publish with us

Policies and ethics

Search

Navigation